Moderna, Inc. vs Vivus
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $29 M for Vivus, 3108 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 1, 2020 for Vivus). Vivus's value is the last on file, from Jan 1, 2020: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $70 M for Vivus in the year to December 2019.
- Both made a net loss: $2.8 B for Moderna, Inc. and $32 M for Vivus.
- Vivus keeps more of each dollar of sales: a net margin of -45.2% against -145.2% for Moderna, Inc.
Market cap history
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Moderna, Inc. MRNA · #275 in the world | Vivus VVUS |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | 1991 |
| Size | ||
| Market cap | $90.1 B | $29 M* |
| Revenue | $1.9 B | $70 M |
| Net income | $-2.8 B | $-32 M▲ best |
| Employees | 4,700 | — |
| Valuation | ||
| Price to sales | 35.7× | — |
| Price to book | 10.4× | — |
| Free cash flow yield | -2.3% | — |
| Profitability | ||
| Gross margin | 55.4% | — |
| Operating margin | -158.1% | — |
| Net margin | -145.2% | — |
| Return on equity | -28.9% | — |
| Growth | ||
| Revenue growth | -39.9% | — |
| Revenue growth, 3 years a year | -53.4% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -106.2% | — |
| Shareholder returns | ||
| Shareholder yield | 0.0% | — |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2020 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Moderna, Inc. or Vivus?
Moderna, Inc. is the larger company by market value: $90.1 B against $29 M for Vivus, 3108 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 1, 2020 for Vivus). Vivus's value is the last on file, from Jan 1, 2020: no market-data feed is connected for its exchange yet.
Which makes more money, Moderna, Inc. or Vivus?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $70 M for Vivus in the year to December 2019. Both made a net loss: $2.8 B for Moderna, Inc. and $32 M for Vivus.
Which is more profitable, Moderna, Inc. or Vivus?
Vivus keeps more of each dollar of sales: a net margin of -45.2% against -145.2% for Moderna, Inc.
More about Moderna, Inc.
More about Vivus
Sources#
Every figure on this page comes from these, with the date shown next to it.